Kayoko Naiki

Japanese herbal medicine Inchin-ko-to as a therapeutic drug for liver fibrosis

Mie Inao, Satoshi Mochida, Atsushi Matsui et al. · Journal of Hepatology · 2004 · 113 citations

Liver Fibrosis, Hepatology, Traditional Chinese Medicine +13

A Novel Simple Assay System to Quantify the Percent HCV-RNA Levels of NS5A Y93H Mutant Strains and Y93 Wild-Type Strains Relative to the Total HCV-RNA Levels to Determine the Indication for Antiviral Therapy with NS5A Inhibitors

Yoshihito Uchida, Jun‐ichi Kouyama, Kayoko Naiki et al. · PLoS ONE · 2014 · 55 citations · Full text

Development of rare resistance‐associated variants that are extremely tolerant against NS5A inhibitors during daclatasvir/asunaprevir therapy by a two‐hit mechanism

Yoshihito Uchida, Jun‐ichi Kouyama, Kayoko Naiki et al. · Hepatology Research · 2016 · 36 citations

NS5A-P32 deletion as a factor involved in virologic failure in patients receiving glecaprevir and pibrentasvir

Hayato Uemura, Yoshihito Uchida, Jun‐ichi Kouyama et al. · Journal of Gastroenterology · 2019 · 35 citations

Molecular Virology, Ns5a-p32 Deletion, Pathogenesis +5

Significance of switching of the nucleos(t)ide analog used to treat Japanese patients with chronic hepatitis B virus infection from entecavir to tenofovir alafenamide fumarate

Yoshihito Uchida, Masamitsu Nakao, Shohei Tsuji et al. · Journal of Medical Virology · 2019 · 34 citations